More than 4 million packets of Pfizer's Nurtec, a migraine prescription drug, need a fix because the container is not child resistant, the U.S. Consumer Product Safety Commission said March 16.
The affected products are all Nurtec (rimegepant) orally disintegrating tablets, 75 milligram, eight-unit dose blister packs with expiration dates through June 2026.
Because the blister card is not child resistant, there is a risk of poisoning if the contents are swallowed by young children. No injuries have been reported.
Pharmacies nationwide have been contacted.